1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, November 2016 (p3)

Biological Therapy Analysis & Statistics, November 2016 (p3)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

61-90 of about 1000 reports

Purchase Reports From Reputable Market Research Publishers

Liver Fibrosis Global Clinical Trials Review, H2, 2016

Liver Fibrosis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by Global Data

Liver Fibrosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Liver Fibrosis Global Clinical Trials Review, H2, 2016" provides an overview of Liver Fibrosis clinical ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Liver Cirrhosis Global Clinical Trials Review, H2, 2016

Liver Cirrhosis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by Global Data

Liver Cirrhosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Liver Cirrhosis Global Clinical Trials Review, H2, 2016" provides an overview of Liver Cirrhosis clinical ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Pathology, Therapy
  • Countries : World
Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2016

Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by Global Data

Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H2, 2016" ...

  • Industries : Drug Discovery and Development, Pharmaceutical, General Medicine and Specialty Medicine, Pathology
  • Countries : World
Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016

Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • November 2016
  • by Global Data

Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016" provides an overview of ...

  • Industries : Therapy, Pathology, Pharmaceutical, Biological Therapy, Healthcare
  • Countries : World
Natural Killer Cells - Competitive Landscape, Pipeline and Market Analysis, 2017

Natural Killer Cells - Competitive Landscape, Pipeline and Market Analysis, 2017

  • $ 2450
  • Industry report
  • February 2017
  • by Delve Insight

DelveInsight’s, “Natural Killer Cells- Competitive Landscape, Pipeline and Market Analysis, 2017”, report provides comprehensive insights about marketed and pipeline drugs across this Mechanism of ...

  • Industries : Biological Therapy, Therapy
T-Cell Immunotherapy Market (2nd Edition), 2017-2030

T-Cell Immunotherapy Market (2nd Edition), 2017-2030

  • $ 2449
  • Industry report
  • January 2017
  • by Roots Analysis Private Ltd.

INTRODUCTION The concept of immunotherapies dates back to the 18th century; however, since inception, the field has evolved tremendously and is currently cited as one of the most rapidly growing segments ...

  • Industries : Biological Therapy, Biotechnology, Pharmaceutical, Therapy
  • Countries : United States
The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities

The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities

  • $ 2365
  • Industry report
  • January 2017
  • by La Merie Publishing

The Oncolytic Virus Landscape 2017: an analysis of pipeline,stakeholders, deals, industry trends & opportunities The field of oncolytic viruses wasquite dormant in the first decade of the 2000s, characterized ...

  • Industries : Pathology, Therapy, Cancer
  • Countries : United States
Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

  • Industries : Hosting, Hosting, Biological Therapy, Biopharmaceutical
  • Countries : United States
Ornithine-Transcarbamylase Deficiency - Pipeline Review, H2 2016

Ornithine-Transcarbamylase Deficiency - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Ornithine-Transcarbamylase Deficiency - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Ornithine-Transcarbamylase Deficiency – ...

  • Industries : Therapy, Pharmaceutical, Biological Therapy
  • Countries : United States, World
Wounds - Pipeline Review, H2 2016

Wounds - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Wounds - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Wounds – Pipeline Review, H2 2016, provides an overview of the Wounds (Dermatology) ...

  • Industries : Medical Supply, Healthcare, Therapy, Pathology
  • Countries : United States
Androgenic Alopecia - Pipeline Review, H2 2016

Androgenic Alopecia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Androgenic Alopecia - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Androgenic Alopecia – Pipeline Review, H2 2016, provides an ...

  • Industries : OTC, Pharmaceutical
  • Countries : Japan
Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H2 2016

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Mucopolysaccharidosis I (MPS ...

  • Industries : Pathology, Therapy, Healthcare
  • Countries : United States
Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H2 2016

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome ) - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Mucopolysaccharidosis ...

  • Industries : Pathology
  • Countries : United States, World, Sweden
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2016

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Retinitis Pigmentosa (Retinitis) – Pipeline Review, ...

  • Industries : Pathology, Therapy, Biotechnology, Biological Therapy, Pharmaceutical
  • Countries : United States
Age Related Macular Degeneration - Pipeline Review, H2 2016

Age Related Macular Degeneration - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

Age Related Macular Degeneration - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Age Related Macular Degeneration – Pipeline Review, ...

  • Industries : Pathology, General Medicine and Specialty Medicine, Healthcare
  • Countries : United States
Aplastic Anemia - Pipeline Review, H2 2016

Aplastic Anemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Aplastic Anemia - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Pathology
  • Countries : United States
Hepatitis B - Pipeline Review, H2 2016

Hepatitis B - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Hepatitis B - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis B - Pipeline Review, H2 2016, provides an overview of the ...

  • Industries : Pathology, Healthcare
  • Countries : United States, World
Myelodysplastic Syndrome - Pipeline Review, H2 2016

Myelodysplastic Syndrome - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Myelodysplastic Syndrome - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome – Pipeline Review, H2 2016, provides ...

  • Industries : Cancer, Pathology
  • Countries : United States
Neuroblastoma - Pipeline Review, H2 2016

Neuroblastoma - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Neuroblastoma - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroblastoma – Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Cancer, Pathology
  • Countries : United States
Fanconi Anemia - Pipeline Review, H2 2016

Fanconi Anemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Fanconi Anemia - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Fanconi Anemia - Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Pathology
  • Countries : United States, World
Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) – Pipeline ...

  • Industries : Cancer, Pathology
  • Countries : United States
Stroke - Pipeline Review, H2 2016

Stroke - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Stroke - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Stroke – Pipeline Review, H2 2016, provides an overview of the Stroke (Cardiovascular) ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Myelocytic Leukemia ...

  • Industries : Cancer, Pathology
  • Countries : United States
Spinal Cord Injury - Pipeline Review, H2 2016

Spinal Cord Injury - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Spinal Cord Injury - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Cord Injury – Pipeline Review, H2 2016, provides an overview ...

  • Industries : Mental Health, Pathology
  • Countries : United States
Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cytomegalovirus (HHV-5) Infections – Pipeline ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Osteonecrosis - Pipeline Review, H2 2016

Osteonecrosis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • November 2016
  • by Global Markets Direct

Osteonecrosis - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteonecrosis – Pipeline Review, H2 2016, provides an overview of ...

  • Industries : Therapy
  • Countries : United Kingdom, World
Global Cell Banking Market Trends, Opportunities, and Future

Global Cell Banking Market Trends, Opportunities, and Future

  • $ 1500
  • Industry report
  • January 2017
  • by Frost & Sullivan

As Outsourcing of Cell Line Development Services Drives the Market, Contract Service Providers Focus on Providing End-to-end Services by Expanding their Service Portfolio and Collaborating with Biopharmaceutical ...

  • Industries : Banking
  • Countries : World
Genethon SA - Product Pipeline Review - 2016

Genethon SA - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • December 2016
  • by Global Markets Direct

Genethon SA - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Genethon SA - Product Pipeline Review - 2016’, provides an overview of the Genethon SA’s pharmaceutical research and ...

  • Industries : Biological Therapy
  • Countries : World
BioLingus AG - Product Pipeline Review - 2016

BioLingus AG - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • December 2016
  • by Global Markets Direct

BioLingus AG - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘BioLingus AG - Product Pipeline Review - 2016’, provides an overview of the BioLingus AG’s pharmaceutical research ...

  • Industries : Therapy, Pathology, Biological Therapy
  • Countries : World
2016-2021  US Cell Surface Marker Testing Market: Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

2016-2021 US Cell Surface Marker Testing Market: Competitive Strategies, Country Forecasts, Innovative Technologies, Emerging Opportunities

  • $ 1450
  • Industry report
  • November 2016
  • by Venture Planning Group

Complete report $2,050.  DataPack (test volumes, sales forecasts, supplier shares) $1,450. Rationale The use of surface marker identification and classification of cells is spreading beyond lymphocytes ...

  • Industries : Biological Therapy
  • Countries : United States
About 4000 reports

Download Unlimited Documents from Trusted Public Sources

Biological Therapy Industry in the US

  • February 2017
    10 pages
  • Biological Ther...  

  • United States  

View report >

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.